2021 IMF专家共识：多发性骨髓瘤患者塞利尼索的应用和剂量指南

2022-02-04 国际骨髓瘤基金会 Clin Lymphoma Myeloma Leuk

塞利尼索(selinexor)是全球首款用于治疗多发性骨髓瘤（MM）的选择性核输出 (SINE) 抑制药物，可阻断输出蛋白1(XPO1)和致癌蛋白的mRNAs。本文主要针对MM患者应用塞利尼索治疗提供

中文标题：

英文标题：

Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable

发布机构：

国际骨髓瘤基金会

发布日期：

2022-02-04

简要介绍：

塞利尼索(selinexor)是全球首款用于治疗多发性骨髓瘤（MM）的选择性核输出 (SINE) 抑制药物，可阻断输出蛋白1(XPO1)和致癌蛋白的mRNAs。本文主要针对MM患者应用塞利尼索治疗提供共识指导。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ddd311c002a0252a, title=2021 IMF专家共识：多发性骨髓瘤患者塞利尼索的应用和剂量指南, enTitle=Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable, guiderFrom=Clin Lymphoma Myeloma Leuk, authorId=0, author=, summary=塞利尼索(selinexor)是全球首款用于治疗多发性骨髓瘤（MM）的选择性核输出 (SINE) 抑制药物，可阻断输出蛋白1(XPO1)和致癌蛋白的mRNAs。本文主要针对MM患者应用塞利尼索治疗提供, cover=https://img.medsci.cn/202242/1648871106983_1608702.jpg, journalId=0, articlesId=null, associationId=1288, associationName=国际骨髓瘤基金会, associationIntro=, copyright=0, guiderPublishedTime=Fri Feb 04 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>塞利尼索(selinexor)是全球首款用于治疗多发性骨髓瘤（MM）的选择性核输出 (SINE) 抑制药物，可阻断输出蛋白1(XPO1)和致癌蛋白的mRNAs。本文主要针对MM患者应用塞利尼索治疗提供共识指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=321, tagName=多发性骨髓瘤), TagDto(tagId=117037, tagName=髓系疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8124, appHits=97, showAppHits=0, pcHits=269, showPcHits=8027, likes=1, shares=12, comments=0, approvalStatus=1, publishedTime=Sat Apr 02 15:43:00 CST 2022, publishedTimeString=2022-02-04, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Sat Apr 02 11:46:13 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 10:30:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 IMF专家共识：多发性骨髓瘤患者塞利尼索的应用和剂量指南.pdf)])